U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Chronic Kidney Disease, Stage 0

MedGen UID:
414191
•Concept ID:
C2825158
•
Disease or Syndrome

Definition

Long-standing and persistent renal disease without kidney damage. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVChronic Kidney Disease, Stage 0

Professional guidelines

PubMed

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
Agrawal U, Bedston S, McCowan C, Oke J, Patterson L, Robertson C, Akbari A, Azcoaga-Lorenzo A, Bradley DT, Fagbamigbe AF, Grange Z, Hall ECR, Joy M, Katikireddi SV, Kerr S, Ritchie L, Murphy S, Owen RK, Rudan I, Shah SA, Simpson CR, Torabi F, Tsang RSM, de Lusignan S, Lyons RA, O'Reilly D, Sheikh A
Lancet 2022 Oct 15;400(10360):1305-1320. doi: 10.1016/S0140-6736(22)01656-7. PMID: 36244382Free PMC Article

Recent clinical studies

Etiology

Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy.
Park JS, Minn D, Hong S, Jeong S, Kim S, Lee CH, Kim B
J Korean Med Sci 2022 Jun 13;37(23):e180. doi: 10.3346/jkms.2022.37.e180. PMID: 35698835Free PMC Article
Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine.
Qureshi MIA, Azam B, Waheed MA, Imran A
BMJ Case Rep 2022 May 20;15(5) doi: 10.1136/bcr-2021-247493. PMID: 35606039Free PMC Article
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Hsu CM, Weiner DE, Manley HJ, Aweh GN, Ladik V, Frament J, Miskulin D, Argyropoulos C, Abreo K, Chin A, Gladish R, Salman L, Johnson D, Lacson EK Jr
Clin J Am Soc Nephrol 2022 Mar;17(3):403-413. Epub 2022 Feb 10 doi: 10.2215/CJN.12250921. PMID: 35144972Free PMC Article
Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up.
Ben-Dov IZ, Oster Y, Tzukert K, Alster T, Bader R, Israeli R, Asayag H, Aharon M, Burstein I, Pri-Chen H, Imam A, Abel R, Mor-Yosef Levi I, Khalaileh A, Oiknine-Djian E, Bloch A, Wolf DG, Dranitzki Elhalel M
J Nephrol 2022 Jan;35(1):153-164. Epub 2022 Jan 6 doi: 10.1007/s40620-021-01210-y. PMID: 34988942Free PMC Article
Immunogenicity of SARS-CoV-2 Vaccine in Dialysis.
Lacson E Jr, Argyropoulos CP, Manley HJ, Aweh G, Chin AI, Salman LH, Hsu CM, Johnson DS, Weiner DE
J Am Soc Nephrol 2021 Nov;32(11):2735-2742. Epub 2021 Aug 4 doi: 10.1681/ASN.2021040432. PMID: 34348908Free PMC Article

Therapy

Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine.
Piotrowska M, Zieliński M, Tylicki L, Biedunkiewicz B, Kubanek A, Ślizień Z, Polewska K, Tylicki P, Muchlado M, Sakowska J, Renke M, Sudoł A, Dąbrowska M, Lichodziejewska-Niemierko M, Smiatacz T, Dębska-Ślizień A, Trzonkowski P
Front Immunol 2022;13:832924. Epub 2022 Jul 22 doi: 10.3389/fimmu.2022.832924. PMID: 35935974Free PMC Article
Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy.
Park JS, Minn D, Hong S, Jeong S, Kim S, Lee CH, Kim B
J Korean Med Sci 2022 Jun 13;37(23):e180. doi: 10.3346/jkms.2022.37.e180. PMID: 35698835Free PMC Article
Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine.
Qureshi MIA, Azam B, Waheed MA, Imran A
BMJ Case Rep 2022 May 20;15(5) doi: 10.1136/bcr-2021-247493. PMID: 35606039Free PMC Article
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Hsu CM, Weiner DE, Manley HJ, Aweh GN, Ladik V, Frament J, Miskulin D, Argyropoulos C, Abreo K, Chin A, Gladish R, Salman L, Johnson D, Lacson EK Jr
Clin J Am Soc Nephrol 2022 Mar;17(3):403-413. Epub 2022 Feb 10 doi: 10.2215/CJN.12250921. PMID: 35144972Free PMC Article

Prognosis

Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up.
Ben-Dov IZ, Oster Y, Tzukert K, Alster T, Bader R, Israeli R, Asayag H, Aharon M, Burstein I, Pri-Chen H, Imam A, Abel R, Mor-Yosef Levi I, Khalaileh A, Oiknine-Djian E, Bloch A, Wolf DG, Dranitzki Elhalel M
J Nephrol 2022 Jan;35(1):153-164. Epub 2022 Jan 6 doi: 10.1007/s40620-021-01210-y. PMID: 34988942Free PMC Article

Clinical prediction guides

Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine.
Piotrowska M, Zieliński M, Tylicki L, Biedunkiewicz B, Kubanek A, Ślizień Z, Polewska K, Tylicki P, Muchlado M, Sakowska J, Renke M, Sudoł A, Dąbrowska M, Lichodziejewska-Niemierko M, Smiatacz T, Dębska-Ślizień A, Trzonkowski P
Front Immunol 2022;13:832924. Epub 2022 Jul 22 doi: 10.3389/fimmu.2022.832924. PMID: 35935974Free PMC Article
Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up.
Ben-Dov IZ, Oster Y, Tzukert K, Alster T, Bader R, Israeli R, Asayag H, Aharon M, Burstein I, Pri-Chen H, Imam A, Abel R, Mor-Yosef Levi I, Khalaileh A, Oiknine-Djian E, Bloch A, Wolf DG, Dranitzki Elhalel M
J Nephrol 2022 Jan;35(1):153-164. Epub 2022 Jan 6 doi: 10.1007/s40620-021-01210-y. PMID: 34988942Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...